Nicotine impairs endothelium-dependent dilatation in human veins in vivo

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 4, 2000, Pages 391-397

  Chalon, Stephan ^a,b   Moreno Jr , Heitor ^a,b   Benowitz, Neal L ^a,b   Hoffman, Brian B ^a,b   Blaschke, Terrence F ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; NICOTINE;

ARTICLE; BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM INJURY; HUMAN; IN VIVO STUDY; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VEIN COMPLIANCE; VEIN DILATATION;

EID: 0034015643     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.105153     Document Type: Article

References (39)

1. 1. Jonas MA, Oates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for health care professionals. Circulation 1992;86:1664-9.
2. 2. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
3. 3. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994;90:27-34.
4. 4. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-100.
5. 5. Heitzer T, Ylä-Herttuala S, Luoma J, Kurz S, Münzel T, Just H, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation 1996;93:1346-53.
6. 6. Heitzer T, Just H, Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6-9.
7. 7. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M, et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol 1997;273:H1644-50.
8. 8. Higman DJ, Greenhalgh RM, Powell JT. Smoking impairs endothelium-dependent relaxation of saphenous vein. Br J Surg 1993;80:1242-5.
9. 9. Higman D, Strachan AMJ, Buttery L, Hicks RCJ, Springall DR, Greenhalgh RM, et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vase Biol 1996;16:546-52.
10. 10. Moreno H Jr, Chalon S, Urae A, Tangphao O, Abiose AK, Huffman BB, et al. Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol 1998;275(3 Pt 2):H1040-5.
11. 11. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997;30:325-33.
12. 12. Zhu BQ, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 1995; 130:1270-5.
13. 13. Mayhan WG, Patel KP. Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo. Am J Physiol 1997;272:H2337-42.
14. 14. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial hand veins - 1. Br J Clin Pharmacol 1994;38:181-96.
15. 15. Pan HYM, Hoffman BB, Pershe RA, Blaschke TF. Decline in beta-adrenergic receptor mediated vascular relaxation with aging in man. J Pharmacol Exp Ther 1987;239:802-7.
16. 16. Dachman WD, Ford GA, Blaschke TF, Hoffman BB. Mechanism of bradykinin-induced venodilation in humans. J Cardiovasc Pharmacol 1993:21:241-8.
17. 17. Gourlay SG, Benowitz NL. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther 1997;62:453-63.
18. 18. Okamura T, Toda N. Different involvement of endothelium-derived relaxing factor and prostacyclin in vasodilator response to bradykinin in isolated dog blood vessels. Adv Exp Med Biol 1989;247:429-34.
19. 19. Bohme E, Graf H, Schültz G. Effect of sodium nitroprus-side and other smooth muscle relaxants on cyclic-GMP formation in smooth muscle and platelets. Adv Cyclic Nucl Res 1978;9:131-43.
20. 20. Jacobs P 3d, Wilson M, Benowitz NL. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr 1981; 222:61-70.
21. 21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-10.
22. 22. Creager MA, Cooke JP, Mendelson ME, Gallagher SJ, Coleman SM, Loscalzo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-34.
23. 23. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-6.
24. 24. Panza JA, Quiyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
25. 25. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL, Lopez JAG, Winniford MD. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993;22:642-7.
26. 26. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-31.
27. 27. Lekakis J, Papamichael C, Vemmos C, Nanas J, Kontoyannis D, Stamatelopolous S, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997;79:529-31.
28. 28. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Toxicol 1996;36:597-613.
29. 29. Booyse FM, Osikowicz G, Quarfoot AJ. Effects of chronic oral consumption of nicotine on the rabbit aortic endothelium. Am J Pathol 1981;102:229-38.
30. 30. Zimmerman M, McGeachie J. The effect of nicotine on aortic endothelium: a quantitative ultrastructural study. Atherosclerosis 1987;63:33-41.
31. 31. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S. Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler Thromb Vase Biol 1992; 12:1305-12.
32. 32. Bedarida G, Kim D, Blaschke TF, Hoffman BB. Characterization of an inhibitor of nitric oxide synthase in human hand veins. Horm Metab Res 1994;26:109-12.
33. 33. Shirasaki Y, Su C. Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur J Pharmacol 1985;114:93-6.
34. 34. Lüscher TF, Richard V, Yang Z. Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels. J Cardiovasc Pharmacol 1989;14 (suppl 11):S76-80.
35. 35. Moncada S, Rees DD, Schultz R, Palmer RMA. Development and mechanisms of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthase in vivo. Proc Natl Acad Sci USA 1991;88:2166-70.
36. 36. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by Superoxide anion-mediated degradation of EDRF. Am J Physiol 1994;266:H874-80.
37. 37. Ota Y, Kugiyama K, Sugiyama S, Ohgushi M, Matsumura T, Doi H, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract: role of free radicals and attenuation by captopril. Atherosclerosis 1997;131:195-202.
38. 38. Mayhan WG, Sharpe GM. Nicotine impairs histamine-induced increases in macromolecular efflux: role of oxygen radicals. J Appl Physiol 1998;84:1589-95.
39. 39. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97:916-31.